What's breaking now, across thousands of outlets.
Researchers compared 70 psilocybin trial publications with 172 news articles. Both reported positive results at similar rates, but news coverage tended to present the benefits as established and rarely discussed the small, early-stage nature of the research.
We haven't written up this one. PsyPost has the full story — the link below goes straight to it.
Discover our top picks of biotech incubators in Europe giving life science startups the boost they need to get off the ground.
GOBLET Cohort 4 demonstrates approximately 15-month median duration of response that exceeds historical results for approved second-line checkpoint inhibitor monotherapy 100% of responding patients…
BUNIA, Congo — The fast-moving Ebola outbreak in Congo has reached 10,000 confirmed cases, government data showed Tuesday, as health authorities race to slow the spread of the disease in multiple…
Researchers in China have discovered that the vitamin B5 derivative pantethine limits the activity of immune cells that are key contributors to autoimmune diseases such as psoriasis.
Randomised trials of omega-6s do not show an increase in inflammation caused by the fatty acid Once a completely innocuous food that no one really talked about, they have become the enemy of the…
India, Mexico, Georgia, Ukraine, and Thailand court foreign IVF patients with per-cycle prices, travel support, and legal options
